Novel Approaches for Vaccination Against HPV-Induced Cancers.
To date, more than 5 % of all cancers are as a result of human papillomavirus (HPV) infection, and this incidence is increasing. Early recognition of disease is associated with good survival, but late presentation results in devastating consequences. Prevention is better than cure, and there are now successful prophylactic vaccination programmes in place. We discuss these and the prospect of therapeutic vaccinations in the near future to address a growing need for improved therapeutic options.
University of Southampton, Southampton, UK. e.king@soton.ac.uk.
Emma
E
King
University of Southampton, Southampton, UK.
Christian
C
Ottensmeier
Health Protection Scotland, Glasgow, Scotland. kevin.pollock@nhs.net.
Kevin G J
KGJ
Pollock
D006801:Humans; D009369:Neoplasms / Q000517:prevention & control* / Q000628:therapy* / Q000821:virology; D027383:Papillomaviridae / Q000276:immunology* / Q000472:pathogenicity*; D030361:Papillomavirus Infections / Q000517:prevention & control* / Q000628:therapy* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000276:immunology* / Q000627:therapeutic use*; D014611:Vaccination / Q000379:methods
D053918:Papillomavirus Vaccines